People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Scientia Vascular, Inc. | — | Other Health Care | Series C | $55.0M | $48.2M | 2023 |
Nathan M. Dau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nathan M. Dau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mahendra Shah | 1 | 5 |
| David Bearss | 1 | 5 |
| Joseph Siletto | 1 | 2 |
| Jerry Henley | 1 | 2 |
| John Lippert | 1 | 1 |
| Stacy Lippert | 1 | 1 |
| Larry Myres | 1 | 1 |
| Rick Randall | 1 | 1 |
| De Lyle Bloomquist | 1 | 1 |
| Janet M. Lowe | 1 | 1 |
| Huy M. Do | 1 | 1 |
| Jeffrey M. Gladden | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.